secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001193125-24-228322
Event type: litigation
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience wins arbitration; panel finds no breach, no damages to EOC
--------------------------------------------------------------------------

- Arbitration panel issued Final Award on Sept 26, 2024, in favor of Aadi Bioscience.
- Panel concluded Aadi did not breach the December 2020 EOC License Agreement.
- EOC Pharma sought monetary damages; none awarded.
- Dispute began in June 2022, centered on alleged failure to provide manufacturing info.
- Outcome removes a significant legal overhang for the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524228322/0001193125-24-228322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524228322/d871823d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-228322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer